<DOC>
	<DOCNO>NCT01602185</DOCNO>
	<brief_summary>The aim study evaluate memantine dextromethorphan give relay ketamine maintain induces decrease pain intensity . In clinical , ketamine cure , clinician often difficulty treat patient order maintain analgesia suggest another treatment analgesia induce ketamine effective , occur one quarter patient . It useful monitor painful patient evaluate memantine dextromethorphan could effective therapeutic alternative neuropathic pain treatment .</brief_summary>
	<brief_title>Study NMDA Antagonists Neuropathic Pain</brief_title>
	<detailed_description>The aim study evaluate memantine dextromethorphan give relay ketamine maintain induces decrease pain intensity . In clinical , ketamine cure , clinician often difficulty treat patient order maintain analgesia suggest another treatment analgesia induce ketamine effective , occur one quarter patient . It useful monitor painful patient evaluate memantine dextromethorphan could effective therapeutic alternative neuropathic pain treatment .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Antitussive Agents</mesh_term>
	<criteria>&gt; 18 year old patient suffer chronic neuropathic pain All chronic pain retain except central diabetic pain Answering patient ketamine pain treatment investigator , already receive ketamine Patient complete ketamine follow evaluation : DN4 , QCD , QDSA , PGIC questionnaires , HAD scale , Leed 's sleep evaluation SF36 . Patient complete end treatment follow evaluation : numerical scale PGIC Sufficient cooperation understand comply requirement study Acceptance give write concert Affiliation system French social security Inscription acceptation inscription national register voluntary participant research Againstindication memantine dextromethorphan administration : hypersensitivity active substance excipients , hypertension , antecedent cerebrovascular accident , severe cardiac insufficiency Patient medical surgical antecedent Patient progressive disease balance inclusion Patient treat IMAO Woman childbearing age use effective contraceptive method , pregnant lactate woman Patient participate another clinical trial , locate exclusion period receive benefit &gt; 4500 euro 12 month begin trial Patient cooperation understand insufficiency comply requirement protocol Patient social protection No affiliation system French social security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>NMDA ( N-Methyl-D-Aspartate ) antagonist</keyword>
	<keyword>ketamine</keyword>
	<keyword>memantine</keyword>
	<keyword>dextromethorphan</keyword>
	<keyword>Neuropathic pain</keyword>
</DOC>